Asia Insurance Post
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
Select Page

Nasal spray lowers Covid viral load by 94 percent in 24 hours: Lancet study

by AIP Online Bureau | Jul 14, 2022 | Facts, Health, Pandemic

NONS was launched in India under the brand name FabiSpray in February after it received manufacturing and marketing approval from the Drugs Controller General of India (DCGI) as part of the accelerated approval process. Nitric Oxide blocks entry into the nasal passage...

First nasal spray for treating adult COVID-19 patients launched in India

by AIP Online Bureau | Feb 9, 2022 | Eco/Invest/Demography, Facts, Health, Pandemic

Terming the spray an effective and safe antiviral treatment for COVID-19, Glenmark Pharmaceuticals Ltd’s Chief Commercial Officer Robert Crockart said “we are confident it will offer patients a much needed and timely therapy option.” Mumbai: Mumbai...

Recent Posts

  • Venezuela faces $6.7 billion in economic losses from earthquakes:UNDP
  • Iran and US step up attacks and threaten to escalate
  • Extreme heat kills more than 1,300 across Europe
  • CertIn warns against malware campaign spreading through WhatsApp web
  • Nadda to launch Aarogya Setu 2.0 and other digital Initiatives for health sector on Monday

Categories

  • Articles
  • Banking & Bancassurance
  • Blog
  • Breaking News!
  • Briefs
  • Climate, Environment, Renewable Energy
  • Data
  • Disaster & Management
  • Eco/Invest/Demography
  • Editorial
  • Events
  • Facts
  • Features
  • Health
  • Indian News
  • Intermediaries
  • International News
  • Interviews
  • Life
  • Main Menu
  • Non-Life
  • Pandemic
  • Pension & Social Security
  • Policy
  • Regulation
  • Reinsurance
  • Risk Management
  • Simple
  • Technology
  • Trends, Facts
  • Uncategorized
  • Wealth Management/ Philanthropy
  • Workplace/Employee Benefits
  • Home
  • Articles
  • Blog
  • Data
  • Facts
  • Editorial
  • Interviews
  • Eco/Invest/Demography
  • Indian News
  • International News
  • Health
  • Non-Life
  • Pandemic
  • Technology
  • Risk Management
  • Reinsurance
  • Banking & Bancassurance
  • Wealth Management/ Philanthropy